Openings - Hong Kong Center for Neurodegenerative Diseases Limited

Hong Kong Center for Neurodegenerative Diseases Limited (HKCeND) incorporated in March 2020 is hosted by The Hong Kong University of Science and Technology as a research center for advanced research on neurodegenerative diseases in Hong Kong. HKCeND teams up with prominent research investigators from the Boston Children’s Hospital (Harvard Medical School), Stanford University School of Medicine, and University College London (UCL) to collectively establish a hub harboring state-of-the-art technological platforms for the generation of new insights on disease pathways, identification of disease-associated targets and potential drug candidates, and development of effective clinical interventions, diagnostics and prognostics for neurogenerative diseases. The Center harness the power to make translational impact in the area of neurogenerative diseases.